Drug Type Small molecule drug |
Synonyms (RS)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole, 2-(1,2,3,4-Tetrahydro-1-naphthyl)-2-imidazoline, 2-Tetralin-1-yl-4,5-dihydro-1H-imidazole + [7] |
Target |
Mechanism ADRA1 agonists(Adrenergic receptor alpha-1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (30 Nov 1979), |
Regulation- |
Molecular FormulaC13H17ClN2 |
InChIKeyBJORNXNYWNIWEY-UHFFFAOYSA-N |
CAS Registry522-48-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Tetrahydrozoline Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Nasal Obstruction | US | 30 Nov 1979 |
Not Applicable | - | ukxuqapbwy(ozppyrrggr) = qadnsasdxm qvidviboml (ljiluddmkd ) View more | - | 01 Sep 2021 | |||
Control (No Tetrahydrozoline) | ukxuqapbwy(ozppyrrggr) = gbcbjuxgbu qvidviboml (ljiluddmkd ) View more |